Скачать или смотреть WHAT ARE CB1 & CB2 RECEPTORS ? | Andy Yates & Peter O Brien (Artelo Biosciences)

In this episode, we are joined by Andy Yates Ph.D. & Peter O'Brien of Artelo Biosciences. Artelo Biosciences is a clinical-stage company using cutting-edge science to improve patient care. They were founded in 2017 on the promise of therapeutic development based on lipid-signaling modification, including targeting the receptors of the endocannabinoid system. Their aim is to alter the course of treatment for those with a diagnosis of cancer and other serious conditions.

Topics:
1. What are CB1 & CB2 Receptors?
2. Modulating Lipid Signalling Pathways
3. Fatty Acid Binding Proteins

Twitter - @TheCannabisRev2
LinkedIn - @thecannabisreview
Episode Library - https://www.thecannabisreview.ie

https://artelobio.com/